Reaction

Ophthalmoplegia reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,552 reports · 43 co-occurring drugs

As of the last recalculation, Ophthalmoplegia appears in 1,552 FAERS reports alongside 43 co-occurring drug terms. The strongest observed disproportionality signal is ZIDOVUDINE (PRR 79.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Zidovudine	75	79.0	79.4
Nevirapine	50	76.8	77.2
Lopinavir And Ritonavir	56	57.4	57.7
Abacavir Sulfate	40	56.5	56.7
Bupivacaine	32	46.9	47.0
Lamivudine Oral	76	42.3	42.4
Efavirenz	34	41.8	41.9
Ritonavir 100 Mg	41	37.8	37.9
Atazanavir	38	36.3	36.4
Thiamine Hydrochloride	33	36.3	36.4
Tenofovir Disoproxil Fumarate Tablets	23	36.2	36.3
Lamivudine	77	35.1	35.2
Darunavir	34	30.8	30.9
Tenofovir Disoproxil Fumarate	67	28.4	28.4
Raltegravir	28	23.1	23.2
Ritonavir	43	20.3	20.3
Nicotine Polacrilex Mini	22	19.9	20.0
Nicotine Polarilex	22	19.9	20.0
Alemtuzumab	25	17.6	17.6
Phenytoin	24	15.7	15.7
Fingolimod Hcl	95	15.6	15.6
Lidocaine Hydrochloride And Epinephrine Bitartrate	58	15.1	15.1
Lidocaine Hydrochloride	59	13.6	13.6
Botulinum Toxin Type A	12	13.1	13.1
Ravulizumab	13	13.0	13.0
Lidicaine	39	10.9	10.9
Burn Relief	39	10.9	10.9
Lidocaine Hydrochloride And Epinephrine	39	10.9	10.9
Adrenalinum	33	10.9	10.9
Siponimod	7	10.6	10.6
Minocycline	9	10.4	10.4
Lidocaine 4%	41	10.3	10.3
Naltrexone	20	8.8	8.8
Onabotulinumtoxina	47	8.4	8.4
Rifampin	9	8.3	8.3
Nicotine Polacrilex	22	7.8	7.8
Nicotine	23	7.7	7.7
Linezolid	15	6.8	6.8
Latanoprost	24	6.5	6.5
Pembrolizumab	44	5.7	5.7
Dalfampridine	23	4.3	4.4
Glatiramer Acetate	19	4.3	4.3
Ipilimumab	13	4.1	4.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.